hBChE-IN-1 can be used in the study of Alzheimer's disease; it exhibits inhibitory activity against tau and Aβ40 protein aggregation (IC50 = 20 μM and 4.3 μM, respectively) and acts as a potent and selective inhibitor of human butyrylcholinesterase (hBChE) over human acetylcholinesterase (hAChE) (IC50 = 7 nM).